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Abstract: 
Toxoplasma gondii ME49 is an obligatory intracellular apicomplexa parasite that causes toxoplasmosis in humans, domesticated and 
wild animals. Waterborne outbreaks of acute toxoplasmosis worldwide reinforce the transmission of Toxoplasma gondii ME49 to 
humans through contaminated water and may have a greater epidemiological impact than previously believed. In the quest for 
drug and vaccine target identification subtractive genomics involving subtraction between the host and pathogen genome has been 
implemented for enlisting essential pathogen specific proteins. Using this approach, our analysis on both human and Toxoplasma 
gondii ME49 reveals that out of 7987 protein coding sequences of the pathogen, 950 represent essential non human-homologous 
proteins. Subcellular localization prediction & comparative-biochemical pathway analysis of these essential proteins gives a list of 
apicoplast-associated proteins having unique pathogen-specific metabolic pathway. These apicoplast-associated enzymes involved 
in fatty acid biosynthesis pathway of Toxoplasma gondii ME49, may be used as potential drug targets, as the pathway is vital for the 
protozoan’s survival. Structure prediction of drug target proteins was done using fold based recognition method. Screening of the 
functional inhibitors against these novel targets may result in discovery of novel therapeutic compounds that can be effective 
against Toxoplasma gondii ME49. 
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Background: 
Toxoplasma gondii is arguably the most successful parasitic 
organism in the world. It can infect all warm-blooded animals, 
including people, and causes a wide spectrum of disease 
severity in the different host species, ranging from acute fatal 
disease in marsupials and marine mammals through to very 
mild clinical signs in other hosts. Toxoplasma gondii ME49 is an 
obligatory intracellular Apicomplexa parasite, with a complex 
life cycle, that causes toxoplasmosis in humans, domesticated 
and wild animals[1].Toxoplasmic encephalitis (TE) caused by 
Toxoplasma gondii ME49 remains an important human disease, 
particularly in immuno-suppressed individuals . Murine 
models employing the ME49 strain of Toxoplasma gondii  have 
been developed and used to study the pathogenesis and 
therapy of TE[2][3][4]. The ME49 strain of Toxoplasma gondii is of 
typeII, which has been reported as the type most frequently 
associated with human disease. Infection is usually 
asymptomatic in people with a normal immune function and 
occasionally results in eye involvement. Toxoplasmosis can 
cause severe disease in foetuses of acutely infected pregnant 
woman, immuno-compromised individuals (AIDS) and 
therapeutically immuno-suppressed patients, as cancer or 
transplant recipients. Toxoplasma gondii ME49 is a protozoan 
parasite that is uniquely adapted for penetrating and surviving 
within a wide range of host cells. This parasite invades BIOINFORMATION  open access 
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mammalian cells by an active actin-dependent mechanism, and 
after entry establishes a vacuole with the assistance of products 
secreted by the parasite’s apical organelles [5]. 
 
One of the unique features of Toxoplasma gondii ME49 is the 
presence of a non-photosynthetic plastid called apicoplast (6-15) 
containing its own 35-kilobase genome, which is essential for 
parasite survival. Antibiotics that apparently target plastid 
protein synthesis specifically block parasite replication [9, 10]. It 
has been postulated that the apicomplexan plastid was acquired 
by endosymbiosis of an alga [6, 7, 11]. The plastid is bounded 
by four membranes, and its genome shows substantial sequence 
similarity to algal and other chloroplast DNA 
[7,8,9,11].Although the metabolic functions of this degenerate 
plastid remain largely unknown, it is possible that it provides a 
site for fatty acid biosynthesis [14,15]. Recent studied has 
revealed directly linkage between apicoplast function and 
parasite survival, validating this intriguing organelle as an 
effective target for parasiticidal drug design.  
 
In quest for developing new potent drug candidates against 
Toxoplasma gondii cell-based drug development strategy has 
been in use in past decade. In cell-based drug development, 
researchers attempt to create drugs that kill a pathogen without 
necessarily understanding the details of how the drugs work. In 
contrast, target-based drug development entails the search for 
compounds that act on a specific intracellular target—often a 
protein known or suspected to be required for survival of the 
pathogen. The latter approach to drug development has been 
facilitated greatly by the sequencing of many pathogen 
genomes.  
 
T o  i d e n t i f y  a p i c o p l a s t  a s s o c i a t e d  d r u g  t a r g e t s  w e  h a v e  
implemented the concept of subtractive genomics approach in 
which the subtraction dataset between the host and pathogen 
genome provides information of pathogen-specific essential 
proteins. This approach has been used successfully in recent 
times to identify essential genes in Pseudomonas aeruginosa. We 
have used the same methodology to analyse the whole genome 
sequence of the Toxoplasma gondii ME49. The differences in the 
proteins of the host and the pathogen can be effectively used for 
designing a drug specifically targeting the pathogen. 
 
Methodology:  
The process-flow of the methodology is displayed in Figure 1. 
 
Retrieval of Proteomes of Host and Pathogen 
The complete proteome of Toxoplasma gondii ME49 & Homo 
sapiens was retrieved from NCBI. Eukaryotic essential protein 
sequences were retrieved from the database of essential genes 
(DEG) [16] from its location (http://tubic.tju.edu.cn/deg/) by 
manual annotation. 
 
Identification of Essential Proteins in Toxoplasma gondii 
ME49 
Toxoplasma gondii ME49 proteome was purged at 20% threshold 
using CD-HIT [17] to exclude paralogs or duplicates for further 
analysis. The set of proteins obtained were subjected to Blastp 
against Homo sapiens proteome with the expectation value (E-
value) cut-off of 10-4. The protein sequences of Toxoplasma 
gondii ME49 showing no significant similarity with Homo 
sapiens proteome was retrieved manually. Blastp analysis was 
performed for the non homologous protein sequences of 
Toxoplasma gondii ME49 against database of essential proteins 
retrieved from DEG with E-value cut off score of 10-10 and 30% 
identity. A minimum bit-score cut-off of 100 was used to screen 
out proteins that appeared to represent essential genes. The 
protein sequences obtained are non homologous essential 
proteins of Toxoplasma gondii ME49.  
 
 
Figure 1: Flowchart of the methodology used. CD-HIT = 
Cluster Database at High Identity with Tolerance; NR Set = 
Non-Redundant Set; BLASTP = Basic Local Alignment Search 
Tool Protein; DEG = Database of Essential Genes; PFP Server = 
Protein Function Prediction Server; KEGG = Kyoto 
Encyclopedia of Genes and Genomes; KAAS = KEGG 
Automatic Annotation Server; 
 
Sub Cellular Localization Prediction 
Sub-cellular localization analysis of the essential proteins has 
been done by Proteome Analyst Specialized Sub Cellular 
Localization Server v2.5 (PA-SUB) [18] to identify the location 
of the essential proteins in different cellular organelles.  BIOINFORMATION  open access 
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Metabolic Pathway Analysis 
Metabolic pathway analysis of the essential proteins of 
Toxoplasma gondii ME49 w a s  d o n e  b y  K E G G  A u t o m a t i c  
Annotation Server (KAAS) [19].  Comparative analysis of the 
metabolic pathways of the host and pathogen was performed 
by using Kyoto Encyclopaedia of Genes and Genomes (KEGG) 
pathway database [20] to trace out essential proteins involved 
in pathogen specific metabolic pathways for the identification 
of potential drug targets. 
 
Protein Function Prediction 
Protein function prediction was done using PFP Automated 
Protein Function Prediction Server 
(http://kiharalab.org/web/pfp.php) to find the function of 
uncharacterised essential protein [21]. 
 
Cluster of Orthologous Genes 
  Essential proteins were manually segregated into different 
categories as per the norms of Cluster of Orthologous Genes 
(http://www.ncbi.nlm.nih.gov/COG/). 
 
Structure prediction of drug targets 
 Crystal structures for the enzymes in apicoplast involved in fat 
metabolism are not available in Protein data Bank therefore 
modelling of the target proteins were performed using different 
structure prediction methods. Homology modelling did not 
give good results because of low sequence identity between 
target and template sequence (less than 20%).For getting better 
prediction accuracy fold based prediction using Phyre2 server 
[22] was implemented. Protein threading or fold recognition is a 
method of protein modelling which is used to model those 
proteins which have the same fold as proteins of known 
structures, but do not have homologous proteins with known 
structure. Energy minimization of generated 3D-model was 
done through GROMACS (OPLS force field) by using Steepest 
Descent and Conjugate Gradient Algorithms. Parameters like 
covalent bond distances and angles, stereo-chemical validation, 
atom nomenclature were validated using RAMPAGE and 
overall quality factor of non-bonded interactions between 
different atoms types were measured by ERRAT program. 
RMSD (root-mean-square deviation) and RMSF (Root Mean 
Square Fluctuation) was calculated for modelled structures. 
 
Discussion: 
Toxoplasma gondii ME49 proteome was found to contain 7987 
functional & structural proteins. The protein which had 
conserved region in Human proteome detected by BLASTp was 
excluded for further analysis.  The non homologous proteins 
when analysed with BLASTp in DEG (Database of Essential 
Genes) gave a list of 950   putative uncharacterised essential 
proteins. The 950 essential proteins were grouped into 12 
classes according to COGs functional classification. The sub-
cellular localization prediction for the   950   essential proteins 
of Toxoplasma gondii ME49 was done by using Proteome Analyst 
Specialized Sub Cellular Localization Server v2.5 (PA-SUB) to 
locate the apicoplast associated proteins. Sub-cellular 
localization prediction gave the following set of proteins: 
Apicoplast: 31; Cytoplasm: 396; Periplasm: 3; Mitochondria: 
149; Nucleus:567; Extracellularenvironment:49; 
Plasmamembrane:152;Peroxisome:4;ER:3;Golgiapparatus:5; 
Cytoskeleton:4; Outer membrane: 8 and Lysosome:1. Out of 131 
proteins located in apicoplast which are mentioned above, 75 
are Miscellaneous Enzymes and two of the enzymes glutamate 
dehydrogenase & aspartate amino transferase play an 
important role in the fatty acid biosynthesis pathway. 
 
The KEGG-KAAS analysis identified the biochemical pathways 
of the apicoplast associated proteins. Comparative analysis of 
biochemical pathways of apicoplast associated proteins of 
Toxoplasma gondii ME49 with the pathways of Homo sapiens 
gives 18 proteins which are involved in pathogen-specific 
metabolic pathways. The complete list of the apicoplast 
associated proteins having unique pathways is given in Table 1. 
(See supplementary material) has 18 drug targets which are 
active in pathogen-specific metabolic pathways. Out of those 18 
targets, 16 are engaged in wide-ranging metabolic processes 
and only two are involved in apicoplast-specific fatty acid 
metabolic reactions. Apicoplast-associated fatty acid 
metabolism is very unique to the Toxoplasma gondii and any 
alteration in the direction of this metabolism cascade will be 
fatal to the pathogen & therefore they have good prospects for 
targeting of new drugs. Thus we have considered these proteins 
for further structural & functional analysis. The two drug 
targets identified are Long chain fatty acid CoA ligase & 
Succinate- semi aldehyde dehydrogenase (Figure 2. (a, b)). 
 
 
Figure 2: (a) Modeled structure of Modeled structure of Long-
chain fatty acid CoA ligase (b) Modeled structure of Succinate 
semi-aldehyde dehydrogenase. The structures have been 
viewed using PPG (Protein Picture Generator 
http://bioserv.rpbs.jussieu.fr/PPG) and DINO (Visualizing 
Structural Biology (2002) http://www.dino3d.org) 
 
Drugs designed for these targets can have potent anti-microbial 
activity against the Toxoplasma gondii ME49.X ray 
crystallography or NMR derived structures of these two 
proteins were not available in RCSB-PDB so computational-
approach of   structure prediction was the only alternative. The 
alignment of these two proteins with RCSB-PDB templates gave 
less than 18% identity so homology modelling based approach 
was not a good choice for such a low-alignment of target- 
template. 
 
For structures which have low identity of template-target 
alignment, fold- recognition based structure prediction is 
preferred. Structure prediction using Phyre2 (Protein 
Homology/analogY  Recognition  Engine V 2.0) server was 
employed as described under Methods. (Table 2, see 
supplementary material) represents the summary of Phyre2 
results. The Ramachandran plot analysis (by RAMPAGE) of the BIOINFORMATION  open access 
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model structure from Phyre2 server showed that > 90% of the 
residues is in favoured and additional allowed regions. It 
signifies the good quality of our model. Active site prediction 
using Q-Site Finder 
(http://www.modelling.leeds.ac.uk/qsitefinder) predicts 
pocket of Long chain fatty acid CoA ligase (having site volume 
of 994 Cubic A0) and Succinate- semi aldehyde dehydrogenase 
(having site volume of 618 Cubic A0) which can be used as 
potential inhibitory sites (Figure 2. (a, b)).As apicoplast is 
unique to the protozoa the apicoplast associated essential 
proteins may be attractive drug targets for Toxoplasma gondii 
ME49. Thus, further investigations on the predicted apicoplast 
associated essential proteins are required to verify the reliability 
of the data. 
 
Conclusion:  
The present study has thus led to the identification of several 
apicoplast associated proteins that can be targeted for effective 
drug design against Toxoplasma gondii ME49 .The drugs 
developed against these will be specific to the pathogen, and 
therefore less or non-toxic to the host. Virtual screening against 
these novel targets might be useful in the discovery of novel 
therapeutic compounds against Toxoplasma gondii ME49.This 
research thus draw attention to novel means of finding new 
generation of drug targets for drug resistant microbes.   
 
Abbreviations: 
DEG: Database of Essential Gene; KEGG:  Kyoto Encyclopaedia 
of Genes and Genomes; KAAS:  KEGG Automated Annotation 
Server; PFP: Protein Function Prediction; COG: Cluster of 
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Supplementary material: 
 
Table 1: List of the apicoplast associated drug targets of Toxoplasma gondii ME49 having pathogen specific unique biochemical 
pathways 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Fold based modeling of selected proteins using fold –recognition based computational tool Phyre2 (Protein 
Homology/analogY Recognition Engine V 2.0). Selected template, Coverage, residues aligned fold descriptor, and super family for 
each protein are given 
Protein SCOP 
Code/protein 
PDBID 
Coverage 
(%) 
Residues 
aligned 
Fold/PDB 
descriptor 
Super family  Family 
Long chain fatty 
acid CoA ligase 
d1pg4a_ 95  %  Residues 
23-739 
Acetyl-CoA 
synthetase-like 
Acetyl CoA 
synthetase 
Acetyl-CoA 
synthetase 
Succinate-semi 
aldehyde 
dehydrogenase 
c3ed6B_  97%  Residues  
14-565 
Betaine aldehyde 
dehydrogenase 
Oxidoreductase   Oxidoreductase 
 
 
 
 
 
 
Sl. No  Drug Target Name Predicted  Function 
1  Mov34/MPN/PAD-1 domain  It acts as a regulatory  submit of 26 proteasome 
2 Thioredoxin  reductase 
 
It reduces thioredoxin using NADPH 
3 Succinyl  Co-A  ligase 
 
It is a ADP-forming beta subunit 
4  RNA binding  It is involved in Post-transcriptional events 
5  Long chain fatty acid CoA ligase 
 
It catalyses bio-activation of fatty acids 
6  Heat shock protein 90((Putative)  It has molecular Chaperon activity 
7  60S Ribosomal protein L23(Putative)  It is involved in Binding activity 
8  Hypothetical protein TGME49_112400  No definite function could be identified 
9  Signal Recognition particle 54 kda 
 
The protein is involved in rRNA 
modification guide activity 
10  L-isoaspartate O-methyl transferase  This protein recognises & catalyses the repair of damaged DNA 
11  Pyruvate Kinase  It is involved in Glycolysis 
12 Succinate-  semi  aldehyde  dehydrogenase 
 
It catalyses metabolic reactions of fatty acids 
13  DNA polymerase delta catalytic subunit 
 
It is involved in DNA 
replication and repair 
14  Actin -like family protein ARP4a  It has ATPase activity 
15  Ras family domain  It acts as potential tumour suppressor 
16  5-aminolevulinic acid synthase  It possess pyridoxal 
phosphate binding 
17 Ankyrin  repeat 
 
It has a mediatory role in protein-protein 
interactions 
18  Kelch motif domain  It is involved in cell fusion mechanism 